Precigen, Inc. (PGEN)
7.87
+0.44
(+5.85%)
USD |
NASDAQ |
Sep 17, 16:00
7.90
+0.03
(+0.38%)
After-Hours: 18:07
Precigen Market Cap : 2.818B for Sept. 17, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 16, 2026 | 2.662B |
| September 15, 2026 | 2.506B |
| September 14, 2026 | 2.452B |
| September 11, 2026 | 2.452B |
| September 10, 2026 | 2.391B |
| September 09, 2026 | 2.434B |
| September 08, 2026 | 2.460B |
| September 04, 2026 | 2.542B |
| September 03, 2026 | 2.556B |
| September 02, 2026 | 2.510B |
| September 01, 2026 | 2.456B |
| August 31, 2026 | 2.481B |
| August 28, 2026 | 2.488B |
| August 27, 2026 | 2.574B |
| August 26, 2026 | 2.656B |
| August 25, 2026 | 2.606B |
| August 24, 2026 | 2.567B |
| August 21, 2026 | 2.578B |
| August 20, 2026 | 2.664B |
| August 19, 2026 | 2.563B |
| August 18, 2026 | 2.417B |
| August 17, 2026 | 2.345B |
| August 14, 2026 | 2.184B |
| August 13, 2026 | 2.323B |
| August 12, 2026 | 2.452B |
| Date | Value |
|---|---|
| August 11, 2026 | 2.456B |
| August 10, 2026 | 2.506B |
| August 07, 2026 | 2.588B |
| August 06, 2026 | 2.474B |
| August 05, 2026 | 2.467B |
| August 04, 2026 | 2.338B |
| August 03, 2026 | 2.366B |
| July 31, 2026 | 2.232B |
| July 30, 2026 | 2.114B |
| July 29, 2026 | 1.940B |
| July 28, 2026 | 1.968B |
| July 27, 2026 | 1.929B |
| July 24, 2026 | 1.922B |
| July 23, 2026 | 1.972B |
| July 22, 2026 | 1.893B |
| July 21, 2026 | 1.954B |
| July 20, 2026 | 1.804B |
| July 17, 2026 | 1.762B |
| July 16, 2026 | 1.762B |
| July 15, 2026 | 1.822B |
| July 14, 2026 | 1.822B |
| July 13, 2026 | 1.840B |
| July 10, 2026 | 1.893B |
| July 09, 2026 | 1.968B |
| July 08, 2026 | 1.979B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Aldeyra Therapeutics, Inc. | 83.85M |
| Anika Therapeutics, Inc. | 280.91M |
| AC Immune SA | 244.15M |
| Geron Corp. | 851.27M |
| Neurocrine Biosciences, Inc. | 15.42B |
Market Cap Related Metrics
| PS Ratio | 32.80 |
| PEG Ratio | -0.0457 |
| Price to Book Value | 64.66 |
| Price | 7.87 |
| Earnings Yield | -13.97% |
| PEGY Ratio | -0.0457 |